NEW DRUG DEVELOPMENT

被引：4

作者：

KAYE, SB

机构：

来源：

EUROPEAN JOURNAL OF CANCER | 1991年 / 27卷 / 03期

关键词：

D O I：

10.1016/0277-5379(91)90550-W

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：377 / 380

页数：4

共 30 条

[1]

AKIYAMA T, 1987, J BIOL CHEM, V262, P5592

[2] A CYTO-TOXIC AGENT CAN BE GENERATED SELECTIVELY AT CANCER SITES [J].

BAGSHAWE, KD ;

SPRINGER, CJ ;

SEARLE, F ;

ANTONIW, P ;

SHARMA, SK ;

MELTON, RG ;

SHERWOOD, RF .

BRITISH JOURNAL OF CANCER, 1988, 58 (06) :700-703

[3]

BERDEL WE, 1981, ANTICANCER RES, V1, P345

[4]

BISSERY M C, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P417

[5]

BLUMBERG PM, 1988, CANCER RES, V48, P1

[6] DISTAMYCINS INHIBIT THE BINDING OF OTF-1 AND NFE-1 TRANSFACTORS TO THEIR CONSERVED DNA ELEMENTS [J].

BROGGINI, M ;

PONTI, M ;

OTTOLENGHI, S ;

DINCALCI, M ;

MONGELLI, N ;

MANTOVANI, R .

NUCLEIC ACIDS RESEARCH, 1989, 17 (03) :1051-1059

[7] A PHASE-I EVALUATION OF THE QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR, N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID, CB3717 [J].

CALVERT, AH ;

ALISON, DL ;

HARLAND, SJ ;

ROBINSON, BA ;

JACKMAN, AL ;

JONES, TR ;

NEWELL, DR ;

SIDDIK, ZH ;

WILTSHAW, E ;

MCELWAIN, TJ ;

SMITH, IE ;

HARRAP, KR .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) :1245-1252

[8] EPIRUBICIN - A REVIEW OF THE PHARMACOLOGY, CLINICAL ACTIVITY, AND ADVERSE-EFFECTS OF AN ADRIAMYCIN ANALOG [J].

CERSOSIMO, RJ ;

HONG, WK .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :425-439

[9] IN DEFENSE OF CELL-LINE SCREENING [J].

CHABNER, BA .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) :1083-1085

[10] 9-ALKYL, MORPHOLINYL ANTHRACYCLINES IN THE CIRCUMVENTION OF MULTIDRUG RESISTANCE [J].

COLEY, HM ;

TWENTYMAN, PR ;

WORKMAN, P .

EUROPEAN JOURNAL OF CANCER, 1990, 26 (06) :665-667

← 1 2 3 →